Eligo Bioscience

Developer of in vivo gene editing technology for microbiome modulation

placeParis, Ile De France, France calendar_todayFounded 2014 groups44 employees language eligo.bio

Registered entities

Social engagement

Social engagement: 15.8K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Sanofi Ventures, Khosla Ventures, Seventure Partners.

Investor typeCountShare
Venture capital343%
Accelerator & incubator114%
Bank & private debt229%
Other / undisclosed114%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

15 Jun 2026 · Bioinformatician

9 Sep 2025 · Research Scientist, Internship

31 Jul 2025 · Head of Finance & Corporate Business Excellence

29 Jul 2025 · Microbiology intern

Based on job postings tracked across public sources.

Recent activity

5 Jan 2026
Event
JPM26
18 Dec 2025
Event
Große Research Conferences Conference on Microbiome Editing
1 Dec 2025
Event
8th International Conference on Microbiome Engineering
Coming soon